Items where authors include "Ribeiro, P."
Article
Abani, O., Abbas, A., Abbas, F. et al. (8041 more authors) (2025) Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Infectious Diseases. ISSN 1473-3099
Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. eClinicalMedicine, 81. 103080. ISSN 2589-5370
Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. EClinicalMedicine, 81. 103080. ISSN 2589-5370
Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642
Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642
Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology, 11 (12). pp. 905-914. ISSN 2213-8587
Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 401 (10387). pp. 1499-1507. ISSN 0140-6736
Lavoie, K. orcid.org/0000-0003-2606-1357, Gosselin-Boucher, V. orcid.org/0000-0002-3030-6022, Stojanovic, J. orcid.org/0000-0002-3984-5241 et al. (11 more authors) (2022) Understanding national trends in COVID-19 vaccine hesitancy in Canada: results from five sequential cross-sectional representative surveys spanning April 2020–March 2021. BMJ Open, 12 (4). e059411. ISSN 2044-6055
Proceedings Paper
Shaukat, N., Dubey, S., Kaddouh, B. et al. (8 more authors) (2024) Trustworthy ROS Software Architecture for Autonomous Drones Missions: From RoboChart Modelling to ROS Implementation. In: 2024 20th IEEE/ASME International Conference on Mechatronic and Embedded Systems and Applications (MESA). 2024 20th IEEE/ASME International Conference on Mechatronic and Embedded Systems and Applications (MESA), 02-04 Sep 2024, Genova, Italy. IEEE . ISBN 979-8-3315-1624-6
Shaukat, N., Dubey, S. orcid.org/0000-0002-7365-8474, Kaddouh, B. et al. (8 more authors) (2024) Trustworthy ROS software architecture for autonomous drones missions: from RoboChart modelling to ROS implementation. In: IEEE/ASME International Conference on Mechtronic and Embedded Systems and Applications (MESA). 2024 20th IEEE/ASME International Conference on Mechatronic and Embedded Systems and Applications (MESA), 02-04 Sep 2024, Genova, Italy. Institute of Electrical and Electronics Engineers (IEEE) . ISBN 979-8-3315-1624-6